FDA ex­tends re­search agree­ment with MIT-li­censed or­gan-on-chip sys­tems

The FDA on Wednes­day ex­tend­ed its four-year agree­ment with CN Bio, a de­vel­op­er of sin­gle- and mul­ti-or­gan-on-chip sys­tems used for drug dis­cov­ery, for an­oth­er three years.

CN Bio said the scope of the re­search per­formed by the FDA’s Cen­ter for Drug Eval­u­a­tion and Re­search has ex­pand­ed to in­clude the ex­plo­ration of the com­pa­ny’s lung-on-a-chip sys­tem to help with the agency’s eval­u­a­tion of in­haled drugs, in ad­di­tion to the agency’s work on its liv­er mod­el.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER